KR970703363A - Cyclic Depsipeptide (CYCLODEPSIPEPTIDE) - Google Patents
Cyclic Depsipeptide (CYCLODEPSIPEPTIDE) Download PDFInfo
- Publication number
- KR970703363A KR970703363A KR1019960706672A KR19960706672A KR970703363A KR 970703363 A KR970703363 A KR 970703363A KR 1019960706672 A KR1019960706672 A KR 1019960706672A KR 19960706672 A KR19960706672 A KR 19960706672A KR 970703363 A KR970703363 A KR 970703363A
- Authority
- KR
- South Korea
- Prior art keywords
- cyclic depsipeptide
- pharmacologically acceptable
- acceptable salt
- cyclic
- depsipeptide
- Prior art date
Links
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
하기 화학식(I)의 환상 뎁시펩티드 또는 이의 약리학적으로 허용가능한 염.Cyclic depsipeptide of formula (I) or a pharmacologically acceptable salt thereof.
(식중, n은 정수 5-15이다).(Wherein n is an integer of 5-15).
이는 바실러스 속의 환상 뎁시펩티드-생산 세균을 배양하여 생산하며, 고지혈증 치료, 지질분비 억제제, 및 아폴리포단백질 B 생산 억제제로 유용하다.It is produced by culturing cyclic depsipeptide-producing bacteria of the genus Bacillus and is useful as a treatment for hyperlipidemia, lipid secretion inhibitors, and inhibitors of apolypoprotein B production.
Description
환상 뎁시펩티드(CYCLODEPSIPEPTIDE)Cyclic Depsipeptide (CYCLODEPSIPEPTIDE)
[도면의 간단한 설명][Brief Description of Drawings]
제2도는 본 발명의 환상 뎁시펩티드(화합물 1)의 적외선 흡수 스펙트럼을 나타낸다.2 shows the infrared absorption spectrum of the cyclic depsipeptide (Compound 1) of the present invention.
제3도는 본 발명의 환상 뎁시펩티드(화합물 1)의1H 핵자기공명스펙트럼을 나타낸다.3 shows the 1 H nuclear magnetic resonance spectrum of the cyclic depsipeptide (Compound 1) of the present invention.
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.
Claims (8)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11302394 | 1994-05-26 | ||
JP94-113023 | 1994-05-26 | ||
DEP4418690.8 | 1994-05-28 | ||
DE4418690A DE4418690A1 (en) | 1994-05-28 | 1994-05-28 | Nucleoside 5'-mono-phosphate ester(s) of glyceryl di:ether derivs. |
PCT/JP1995/001003 WO1995032990A1 (en) | 1994-05-26 | 1995-05-25 | Cyclodepsipeptide |
Publications (1)
Publication Number | Publication Date |
---|---|
KR970703363A true KR970703363A (en) | 1997-07-03 |
Family
ID=66437268
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019960706672A KR970703363A (en) | 1994-05-26 | 1995-05-25 | Cyclic Depsipeptide (CYCLODEPSIPEPTIDE) |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR970703363A (en) |
-
1995
- 1995-05-25 KR KR1019960706672A patent/KR970703363A/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9302214A (en) | DERIVATIVES OF TAXOL AND PROCESS FOR ITS PREPARATION | |
NO893021D0 (en) | PROCEDURE FOR PREPARING A BIOLOGICAL ACTIVE COMPOUND, FR 901228. | |
RU94022258A (en) | New sulfonylaminopyrimidines | |
ATE231850T1 (en) | ISOCHROMANIC COMPOUNDS AND METHODS FOR THEIR PRODUCTION | |
ES2155566T3 (en) | USE OF RIFAMYCIN DERIVATIVES FOR THE TREATMENT OF INFECTIOUS DISEASES BY CLAMIDIA. | |
AR007759A1 (en) | NEW HETERO CYCLIC COMPOUNDS, THE USE OF THE SAME TO PREPARE PHARMACEUTICAL COMPOSITIONS, A PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM. | |
DE59002863D1 (en) | LYSOLECITHIN DERIVATIVES FOR THE TREATMENT OF AUTOIMMUNE DISEASES. | |
ATE191849T1 (en) | USE OF (S)-(-)-ALPHA-ETHYL-2-OXO-1-PYRROLIDINEACETAMIDE IN THE PRODUCTION OF A MEDICATION FOR THE TREATMENT OF ANXIETY | |
KR950016727A (en) | How to increase thrombomodulin expression | |
KR920002151A (en) | Inflammatory Disease Treatment with 15-Keto-Prostaglandin Compounds | |
MD1560F2 (en) | Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses. | |
AR046874A1 (en) | NEW METHODS | |
UY25807A1 (en) | SUBSTITUTED CAPROLACTAMAS, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, AND THEIR USE IN THE TREATMENT OF TUMORS. | |
KR970703363A (en) | Cyclic Depsipeptide (CYCLODEPSIPEPTIDE) | |
KR910016938A (en) | Antibiotics GE 2270 Factors B1, B2, C1, C2, D1, D2, E, and T | |
KR910021361A (en) | Anti-ulcer substance | |
MX9201055A (en) | N - [[4,5-DIHIDROXI- Y 4,5,8-TRIHIDROXI-9,10-DIHIDRO-9,10-DIOXO-2-ANTRACEN-IL] CARBONYL] AMINO ACIDS USEFUL IN THE THERAPY OF OSTEOARTICULAR CONDITIONS. | |
KR950702415A (en) | Method of using alpha, omega-dicarboxylic acid as fibrinogen reducing agent (USE OF α, ω-DICARBOXYLIC ACIDS AS FIBRINOGEN REDUCERS) | |
BG101996A (en) | 9-n-ethylenederivatives of 9(s)-erythromycylamine | |
RU94046312A (en) | Use of biologically active ureido-derivatives for treatment lentivirus-induced disease, products containing ureido-derivatives | |
KR920007626A (en) | How to use benzo [b] thiophene-2-carboxyimideamide derivative | |
BR9604843A (en) | Peptide and derivative thereof, and drug and composition to treat osteopathy | |
KR880009644A (en) | Weak composition for treating ulcerative bowel disease | |
ES2066054T3 (en) | NEW ANTIBIOTIC. | |
KR920002497A (en) | Sterol compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Withdrawal due to no request for examination |